Yes, if I could just quickly add in--and thank you for the questions, Anne Minh.
I think the cases that Susan and Feather have enunciated aren't that rare. In some stats I've seen that up to 40% of females diagnosed with breast cancer have dense breast tissue. So it is a huge issue in itself.
We talked about whether we need to broaden it. This bill is specifically about that gap in service. My concern is that if you broaden it after second reading you change the scope of the bill and it is non-receivable. It's very important that we don't make any amendments that would make this non-receivable in the House. I believe that tackling dense breast tissue alone is an important advancement that we need to make in itself.
Feather's story, as someone who is so involved in this and yet didn't know, speaks volumes to the gap that exists in breast cancer screening, particularly on dense breast tissue.